Tumor marker and MR imaging criteria for evaluating the efficacy of cyclic balloon-occluded arterial infusion for advanced cancer of the uterine cervix

Oncology Reports

Volumn 7, Issue 4, 2000, Pages 827-830

  Ishiko, Osamu ^a   Sumi, Toshiyuki ^a   Yasui, Tomoyo ^b   Matsumoto, Yoshinari ^a   Ogita, Sachio ^a   Kaminou, Toshio ^a   Nakamura, Kenji ^a   Yamada, Ryusaku ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hanwa Sumiyoshi General Hospital   (Japan)

Author keywords

Balloon occluded arterial infusion chemotherapy; Cancer of the uterine cervix; Cisplatin; MR imaging; SCC antigen

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT SELECTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; UTERINE CERVIX TUMOR;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0034223545     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.4.827     Document Type: Review

References (17)

1. Souhami L, Gil RA, Allan SE, Canary PCV, Araujo CMM and Pinto LHJ and Silvcira TRP: A randomized trial of chemotherapy followed by pelvic radiation therapy in stage HIb carcinoma of cervix. J Clin Oncol 9: 970-977, 1991.
2. Edelman DZ and Anteby SO: Neoadjuvant chemotherapy for locally advanced cervical cancer-where does it stand? A review. Obstet Gynecol Surv 51: 305-312, 1996.
3. Ishiko O, Sumi T, Yasui T, Matsumoto Y, Kawamura N, Ogita S, Kamino T, Nakamura K and Yamada R: Balloon-occluded arterial infusion chemotherapy, simple total hysterectomy, and radiotherapy as a useful combination-therapy for advanced cancer of the uterine cervix. Oncol Rep 7: 141-144, 2000.
4. Pecorelli S, Benedet JL, Creasman WT and Shepherd JH: FIGO staging of gynecologic cancer. Int J Gynecol Obstet 64: 5-10, 1999.
5. Tsuji K, Yamada R, Kawabata M, Mitsuzane K, Sato M, Iwahashi M, Kitayama S and Nakano R: Effect of balloon occluded arterial infusion of anticancer drugs on the prognosis of cervical cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 32: 1337-1345, 1995.
6. Sironi S, Belloni C, Taccagni G and DelMaschio A: Invasive cervical carcinoma: MR imaging after prospective chemotherapy. Radiology 180: 719-722, 1991.
7. Kim KH, Lee BH, Do YS, Chin SY, Park SY and Kim BG: Stage Ub cervical carcinoma: MR evaluation of effect of intraarterial chemotherapy. Radiology 192: 61-65, 1994.
8. Sardi J, Sananes C, Giaroli A, Maya G and di Paola G: Neoadjuvant chemotherapy in locally advanced cacinoma of the cervix uteri. Gynecol Oncol 38: 486-493, 1990.
9. Hirabayashi K and Okabe E: Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer. Cancer 71: 2769-2775, 1993.
10. Rose PG, Piver MS, Malfetano JH, Baker TR, Hempling RE and Recio FOA: Phase II study of weekly cisplatin and ifosfamide in advanced or recurrent cervical carcinoma. Cancer 71: 2245-2249, 1993.
11. Smith HO, Stringer CA, Kavanagh JJ, Gershenson DM, Edwards CL and Wharton JT: Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy. Gynecol Oncol 48: 11-15, 1993.
12. Lejarcegui JA, Cot X, Lailla JM, Tarrats A, Davi E, Ausin J, Marquez M, Jou P, Guix B and Gonzales-Merlo J: Intraarterial infusion chemotherapy as a primary treatment in cancer of uterine cervix limited to the pelvis. Eur J Gynaecol Oncol 9: 403-409, 1988.
13. Scarabelli C, Tumolo S, Paoli AD, Frustaci S, Campagnutta E, Morassut S, Franchin G, Crivellari D, Sopracordevole F and Lo Re G: Intermittent pelvic arterial infusion with peptichemio, doxorubicin and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix. Cancer 60: 25-30, 1987.
14. Itoh N, Sawairi M, Hanabayashi T, Mori H, Yamawaki Y and Tamaya T: Neoadjuvant Intraarterial infusion chemotherapy with a combination of mitomycin-C, vincristine, and cisplatin for locally advanced cervical cancer: a preliminary report. Gynecol Oncol 47: 391-394, 1992.
15. Nagata Y, Ishigaki T, Okajima K, Fujiwara K, Kinashi T, Mitumori M, Ooya N, Kitakabu Y, Hiraoka M and Abe M: Transcatheter arterial infusion therapy combined with radical hysterectomy in the treatment of advanced cervical cancer. Cardiovasc Intervent Radiol 16: 14-18, 1993.
16. Meier W, Stieber P, Hasholzner U, Baumgartner L and Fateh-Moghadam A: Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma. Anticancer Res 17: 2959-2962, 1997.
17. Sakaguchi Y, Kishi F, Murakami A, Suminami Y and Kato H: Structural analysis of human SCC antigen 2 promoter. Biochim Biophys Acta 18: 111-116, 1999.